August 29, 2016 5:43 AM ET


Company Overview of Mateon Therapeutics, Inc.

Executive Profile

William D. Schwieterman M.D.

Chairman, Chief Executive Officer and President, Mateon Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2015


Dr. William D. Schwieterman, also known as Bill, M.D., has been the Chief Executive Officer and President of Mateon Therapeutics, Inc. since May 12, 2015, and has been its Chairman of the Board since August 18, 2016. Dr. Schwieterman is the Founder of Tekgenics Inc. and serves as its President. Dr. Schwieterman has been the Chief Medical Officer at Chelsea Therapeutics International since November 2009 and serves as its Vice President. He serves as an Advisor at Avidia, ...

Corporate Headquarters

701 Gateway Boulevard
South San Francisco, California 94080

United States

Phone: 650-635-7000
Fax: 650-635-7001

Board Members Memberships

Chairman, Chief Executive Officer and President


University of Cincinnati
University of Cincinnati

Other Affiliations

Annual Compensation

Total Annual Compensation$404,923

Stocks Options

All Other Compensation$111,615
Exercisable Options$33,370
Unexercisable Options$375,000
Total Number of Options$408,370

Total Compensation

Total Annual Cash Compensation$540,538
Total Short Term Compensation$404,923
Other Long Term Compensation$111,615
Total Calculated Compensation$872,309

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Mateon Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at